AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma (Q38818013)
Jump to navigation
Jump to search
scientific article published on 20 November 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma |
scientific article published on 20 November 2015 |
Statements
1 reference
AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma (English)
1 reference
Fernando Doñate
1 reference
Arthur Raitano
1 reference
Kendall Morrison
1 reference
Zili An
1 reference
Linnette Capo
1 reference
Hector Aviña
1 reference
Sher Karki
1 reference
Karen Morrison
1 reference
Peng Yang
1 reference
Jimmy Ou
1 reference
Ryuichi Moriya
1 reference
Yuriy Shostak
1 reference
Faisal Malik
1 reference
Rossana Nadell
1 reference
Wendy Liu
1 reference
Daulet Satpayev
1 reference
John Atkinson
1 reference
Ingrid B J Joseph
1 reference
Daniel S Pereira
1 reference
Pia M Challita-Eid
1 reference
David R Stover
1 reference
20 November 2015
1 reference
1 reference
22
1 reference
8
1 reference
1989-1999
1 reference
Identifiers
1 reference
1 reference